These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28617623)

  • 1. Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.
    Hua X; Phipps AI; Burnett-Hartman AN; Adams SV; Hardikar S; Cohen SA; Kocarnik JM; Ahnen DJ; Lindor NM; Baron JA; Newcomb PA
    J Clin Oncol; 2017 Aug; 35(24):2806-2813. PubMed ID: 28617623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes.
    Amitay EL; Carr PR; Jansen L; Walter V; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    J Natl Cancer Inst; 2019 May; 111(5):475-483. PubMed ID: 30388256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between molecular subtypes of colorectal cancer and patient survival.
    Phipps AI; Limburg PJ; Baron JA; Burnett-Hartman AN; Weisenberger DJ; Laird PW; Sinicrope FA; Rosty C; Buchanan DD; Potter JD; Newcomb PA
    Gastroenterology; 2015 Jan; 148(1):77-87.e2. PubMed ID: 25280443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis.
    Zell JA; Ziogas A; Bernstein L; Clarke CA; Deapen D; Largent JA; Neuhausen SL; Stram DO; Ursin G; Anton-Culver H
    Cancer; 2009 Dec; 115(24):5662-71. PubMed ID: 19827153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
    Hamada T; Cao Y; Qian ZR; Masugi Y; Nowak JA; Yang J; Song M; Mima K; Kosumi K; Liu L; Shi Y; da Silva A; Gu M; Li W; Keum N; Zhang X; Wu K; Meyerhardt JA; Giovannucci EL; Giannakis M; Rodig SJ; Freeman GJ; Nevo D; Wang M; Chan AT; Fuchs CS; Nishihara R; Ogino S
    J Clin Oncol; 2017 Jun; 35(16):1836-1844. PubMed ID: 28406723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.
    Domingo E; Church DN; Sieber O; Ramamoorthy R; Yanagisawa Y; Johnstone E; Davidson B; Kerr DJ; Tomlinson IP; Midgley R
    J Clin Oncol; 2013 Dec; 31(34):4297-305. PubMed ID: 24062397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin use and survival after diagnosis of colorectal cancer.
    Chan AT; Ogino S; Fuchs CS
    JAMA; 2009 Aug; 302(6):649-58. PubMed ID: 19671906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer after start of nonsteroidal anti-inflammatory drug use.
    Stürmer T; Buring JE; Lee IM; Kurth T; Gaziano JM; Glynn RJ
    Am J Med; 2006 Jun; 119(6):494-502. PubMed ID: 16750963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.
    Liao X; Lochhead P; Nishihara R; Morikawa T; Kuchiba A; Yamauchi M; Imamura Y; Qian ZR; Baba Y; Shima K; Sun R; Nosho K; Meyerhardt JA; Giovannucci E; Fuchs CS; Chan AT; Ogino S
    N Engl J Med; 2012 Oct; 367(17):1596-606. PubMed ID: 23094721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.
    Din FV; Theodoratou E; Farrington SM; Tenesa A; Barnetson RA; Cetnarskyj R; Stark L; Porteous ME; Campbell H; Dunlop MG
    Gut; 2010 Dec; 59(12):1670-9. PubMed ID: 20844293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of red and processed meat with survival after colorectal cancer and differences according to timing of dietary assessment.
    Carr PR; Jansen L; Walter V; Kloor M; Roth W; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    Am J Clin Nutr; 2016 Jan; 103(1):192-200. PubMed ID: 26607936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of KRAS mutation with tumor deposit status and overall survival of colorectal cancer.
    Zhang M; Hu W; Hu K; Lin Y; Feng Z; Yun JP; Gao N; Zhang L
    Cancer Causes Control; 2020 Jul; 31(7):683-689. PubMed ID: 32394229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer.
    Kadowaki S; Kakuta M; Takahashi S; Takahashi A; Arai Y; Nishimura Y; Yatsuoka T; Ooki A; Yamaguchi K; Matsuo K; Muro K; Akagi K
    World J Gastroenterol; 2015 Jan; 21(4):1275-83. PubMed ID: 25632202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability.
    Nazemalhosseini-Mojarad E; Kishani Farahani R; Mehrizi M; Baghaei K; Yaghoob Taleghani M; Golmohammadi M; Peyravian N; Ashtari S; Pourhoseingholi MA; Asadzadeh Aghdaei H; Zali MR
    J Gastrointest Cancer; 2020 Mar; 51(1):53-62. PubMed ID: 30635874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.
    Coghill AE; Newcomb PA; Campbell PT; Burnett-Hartman AN; Adams SV; Poole EM; Potter JD; Ulrich CM
    Gut; 2011 Apr; 60(4):491-8. PubMed ID: 21051449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.
    Phipps AI; Alwers E; Harrison T; Banbury B; Brenner H; Campbell PT; Chang-Claude J; Buchanan D; Chan AT; Farris AB; Figueiredo JC; Gallinger S; Giles GG; Jenkins M; Milne RL; Newcomb PA; Slattery ML; Song M; Ogino S; Zaidi SH; Hoffmeister M; Peters U
    Gastroenterology; 2020 Jun; 158(8):2158-2168.e4. PubMed ID: 32088204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study.
    Walker AJ; Grainge MJ; Card TR
    Br J Cancer; 2012 Oct; 107(9):1602-7. PubMed ID: 23011483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.
    Ruder EH; Laiyemo AO; Graubard BI; Hollenbeck AR; Schatzkin A; Cross AJ
    Am J Gastroenterol; 2011 Jul; 106(7):1340-50. PubMed ID: 21407185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
    Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
    J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation.
    Kothari N; Kim R; Jorissen RN; Desai J; Tie J; Wong HL; Faragher I; Jones I; Day FL; Li S; Sakthinandeswaren A; Palmieri M; Lipton L; Schell M; Teer JK; Shibata D; Yeatman T; Sieber OM; Gibbs P; Tran B
    Acta Oncol; 2015 Apr; 54(4):487-92. PubMed ID: 25549537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.